跳至主要内容
临床试验/NL-OMON53779
NL-OMON53779招募中不适用

Protein and calorie restriction as treatment for prevention of cardiotoxicity in women receiving chemotherapy. - The PROTECT-COR trial

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 32 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • In order to be eligible to participate in this study, a subject must meet all
  • of the following criteria:
  • 1. Women with newly diagnosed triple negative or hormone receptor-positive
  • breast cancer with an indication for (neo-)adjuvant anthracycline-based
  • chemotherapy and of intent to start anticancer treatment
  • 2. Age between 18 and 75 years
  • 3. Written informed consent
  • 4. Body mass index >= 19.

排除标准

  • A potential subject who meets any of the following criteria will be excluded
  • from participation in this study:
  • 1. Allergic to any of the ingredients of the diet
  • 2. Known history of cardiac dysfunction
  • 3. Severe morbidity with the inability to receive anticancer treatment.
  • 4. Participation in another clinical trial with an intervention arm (database
  • and/or biobank studies excluded)
  • 5. Pregnant women
  • 6. Previous treatment with anthracycline

研究者

相似试验